Suppr超能文献

TRPA1 作为心肌梗死的靶点。

TRPA1 as Target in Myocardial Infarction.

机构信息

Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.

Center for Biomedical Research and Translational Surgery, Medical University of Vienna, 1090 Vienna, Austria.

出版信息

Int J Mol Sci. 2023 Jan 28;24(3):2516. doi: 10.3390/ijms24032516.

Abstract

Transient receptor potential cation channel subfamily A member 1 (TRPA1), an ion channel primarily expressed on sensory neurons, can be activated by substances occurring during myocardial infarction. Aims were to investigate whether activation, inhibition, or absence of TRPA1 affects infarcts and to explore underlying mechanisms. In the context of myocardial infarction, rats received a TRPA1 agonist, an antagonist, or vehicle at different time points, and infarct size was assessed. Wild type and TRPA1 knockout mice were also compared in this regard. In vitro, sensory neurons were co-cultured with cardiomyocytes and subjected to a model of ischemia-reperfusion. Although there was a difference between TRPA1 activation or inhibition in vivo, no experimental group was different to control animals in infarct size, which also applies to animals lacking TRPA1. In vitro, survival probability of cardiomyocytes challenged by ischemia-reperfusion increased from 32.8% in absence to 45.1% in presence of sensory neurons, which depends, at least partly, on TRPA1. This study raises doubts about whether TRPA1 is a promising target to reduce myocardial damage within a 24 h period. The results are incompatible with relevant enlargements of infarcts by TRPA1 activation or inhibition, which argues against adverse effects when TRPA1 is targeted for other indications.

摘要

瞬时受体电位阳离子通道亚家族 A 成员 1(TRPA1)是一种主要表达于感觉神经元上的离子通道,可被心肌梗死过程中出现的物质激活。本研究旨在探讨 TRPA1 的激活、抑制或缺失是否会影响梗死,并探索潜在的机制。在心肌梗死的背景下,大鼠在不同时间点接受 TRPA1 激动剂、拮抗剂或载体,评估梗死面积。在这方面,还比较了野生型和 TRPA1 敲除小鼠。在体外,感觉神经元与心肌细胞共培养,并进行缺血再灌注模型。尽管体内 TRPA1 的激活或抑制存在差异,但没有一个实验组的梗死面积与对照组动物不同,这也适用于缺乏 TRPA1 的动物。在体外,在没有感觉神经元的情况下,缺血再灌注引起的心肌细胞存活率从 32.8%增加到 45.1%,这至少部分依赖于 TRPA1。本研究对 TRPA1 是否是在 24 小时内减少心肌损伤的有前途的靶点提出了质疑。这些结果与 TRPA1 激活或抑制导致梗死扩大的相关研究结果不一致,这表明当针对其他适应症靶向 TRPA1 时,不会产生不良反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验